Drug Research
Moderna Announces Amendment to Current Supply Agreement with UK Government for an Additional 2 Million Doses of mRNA Vaccine Against COVID-19
Moderna, Inc. , a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the UK government for an additional 2 million doses of mRNA-1273,...
Drug Research
Samsung Biologics breaks ground on Super Plant, the world’s largest and most innovative bio-manufacturing facility
Samsung Biologics officially began construction of its Plant 4 in Incheon, South Korea. Dubbed the “Super Plant,” the new, multi-story 238,000-square-meter construction will be the world’s largest biopharmaceutical manufacturing facility of its kind boasting 256,000 liters total manufacturing capacity.
In...
Drug Research
CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Wacker Chemie AG announced that they had signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV. Under...
Drug Research
Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement
Eli Lilly and Company and Precision BioSciences, Inc. announced a research collaboration and exclusive license agreement to utilize Precision's proprietary ARCUS® genome editing platform for the research and development of potential in vivo therapies for genetic disorders, with an...
Drug Research
Exeter University and Medicines Discovery Catapult collaborate on R&D drive
The collaboration will focus on identifying promising innovations that can be adopted through the industry in the ultimate hope of benefitting patients. The collaboration will combine the world-class research at the University of Exeter with MDC’s industry skills, discovery...
Drug Research
Moderna and Pfizer COVID Vaccines: The Comparison
Moderna Inc. on Monday declared that its vaccine was 94.5% effective.
This came just after a week when Pfizer & its partner BioNTech SE had gone public to state that their vaccine is more than 90% effective.
There is...
Drug Research
COVID-19 Genomics UK Consortium gets £12.2 million funding to expand whole genome sequencing of SARS-CoV-2 virus
The public will be better protected from COVID-19 with £12.2 million of funding awarded to potentially life-saving research into how the virus spreads and evolves through genome sequencing.
The COVID-19 Genomics UK (COG-UK) Consortium will use the funding to expand...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
